Epidemiology: Interpreting Findings Flashcards

1
Q

Define narrative review

A

Brings together published literature into a single article allowing reader to rapidly understand the topic. Also known as critical review, scoping review or non-systematic review.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define systematic review

A

Sets out a highly structured approach to searching, sifting, including and summarising the literature. Underpins meta-analysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the advantages and disadvantages of a narrative review?

A

Adv: Agile so easier and faster to write and hence may be more up to date, allows with rapid understanding of a topic so may be suited to those with limited research or greater variation in research methods, also useful when work from different disciplines is brought together to answer a less-easily answered question.

Disadv: Room for potential bias as authors are free to select included works although robust peer review should prevent overly-speculative or unbalanced reviews,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the advantages and disadvantages of a systematic review?

A

Adv: Collates all available evidence for a focused research question, implements highly specified protocol ensuring reproducibility, only includes evidence based on an inclusion criteria

Disadv: Only as good as method employed (if search not comprehensive, results will not be either), only as good as indices used, becomes out of date quickly due to the sheer amount of time process takes (18-24 months)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are indices and registries?

A

Indices publish articles based on research that has already been conducted while registries contain information on research that is ongoing or hasn’t begun yet. Researchers register their work in registries to prevent duplication of research and publication bias which is underreporting of negative results and overreporting of positive results.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a PRISMA diagram?

A

Shows how many research papers initially identified then how many duplicates were removed, how many papers were screened and excluded through abstracts and finally full text analysis. Shows number of papers at each step.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is grey literature?

A

Reports eg from governments about implementations and programmes. However, these are not always peer reviewed and hence have varying levels of accuracy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define meta-analysis

A

Meta-analysis is a quantitative, formal, epidemiological study design used to systematically assess previous research studies to derive conclusions about that body of research.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the sources of heterogeneity in meta analysis?

A
  1. Clinical: different patient groups, populations and selection criteria used by studies
  2. Methodological: different study designs (blinding, collecting info, recording info)
  3. Statistical: reporting differences
    There are statistical ways of evaluating this heterogeneity between studies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are other considerations when weighing meta analysis?

A
  1. Weighting of study usually depends on study size but we can build in assumptions to account for other similarities and differences. Whether a fixed effects model is used or a random effects model is used for these assumptions will affect the overall weighting of the study.
  2. Publication bias - using a publication funnel plot can help show balance of evidence assuming an overall effect size
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define endpoint

A

An endpoint is an outcome that usually describes a clinically meaningful outcome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the 2 clinical trial outcomes?

A

Efficacy – how well a therapy works in achieving a desired outcome.
Safety – how well a therapy works in not causing adverse events.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the 2 types of efficacy endpoints?

A

Primary endpoint – this is the endpoint for which the study has been powered; that is to say that the number of trial participants (sample size) will have been recruited on the basis of the pre-specified power and difference.
Secondary endpoint – it is common that a study will want to examine a slightly different endpoint in addition to the primary endpoint. For example, while a study seeks to examine survival (i.e. alive or dead) another – often ‘softer’ - measure such as recurrence of disease or hospital admission might also be measured. If the secondary endpoint is proven but the primary endpoint is not, then the findings of the study may still contribute to the understanding of disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is survival analysis?

A

Arbitrary timepoints lead to loss of statistical precision as effects observed may not be the same at different timepoints. Hence, a survival analysis is used which tracks participants across a time period and records when certain events take place.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the Bradford Hill criteria?

A

Enables us to infer causation from both observational and interventional methods. Includes:
Strength: stronger association increases confidence that an exposure caused an outcome
Specificity: Informative when present but its absence doesn’t rule out causality
Temporality: exposure must preceed outcome
Biological response: clear response effect is an indicator of causality
Should be biologically plausible
Coherence: association ought to be consistent with existing theories and knowledge
Evidence from experimentation should support association
Analogy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Define internal validity

A

Where findings are valid and applicable to the study population

17
Q

Define external validity

A

Where findings of a study can be applicable to others apart from the source population. Also known as generalisability. Internal validity is a prerequisite.

18
Q

Define bias

A

Bias is any trend in the collection, analysis, interpretation, publication or review of data that can lead to conclusions that are systematically different from the truth

19
Q

Define selection bias

A

Selection bias occurs when participation is related to both the exposure and the outcome, alterring the magnitude of the association between the exposure and the outcome.

20
Q

What are 3 methods of reducing selection bias?

A
  1. Make sure to select controls representative of the target population
  2. Minimise non-response - the more people that drop out, the greater the chance bias is introduced
  3. Compare respondents with non-respondents and see if there are any systematic differences between the
21
Q

What is misclassification?

A

A form of information bias where participants are wrongly assigned to either exposure or outcome. More likely when study variables are not properly defined or data collection done poorly.

22
Q

What is recall bias?

A

Those suffering from a disease are more likely to recollect events that could have influenced their disease as compared to those without the disease who may have forgotten these details. Can be prevented by using objective methods of assessment.

23
Q

What is non-differential misclassification?

A

Where there are errors with classification among both exposed and unexposed populations or those with a particular outcome and those without. This results in bias towards the null hypothesis.